|
Oct 2
|
At What Oil Price Will Shale Drillers Stop Drilling?
|
|
Aug 27
|
Taylor Fritz’s Girlfriend Morgan Riddle Opts for Classic Little Black Dress on Day One of the U.S. Open 2024
|
|
Aug 7
|
Dow Jones Futures Fuel New Market Rally On Bank Of Japan; Nvidia Partner Super Micro Dives
|
|
Jul 30
|
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jul 30
|
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
|
|
Jul 30
|
Day One Announces Oversubscribed $175.0 Million Private Placement
|
|
Jul 25
|
Ipsen outlines $461m for ex-US rights to Day One’s glioma therapy
|
|
Jun 24
|
Lupita Nyong’o Gives Power Suiting a Sensual Spin in Double-breasted Blazer and High-waisted Shorts for ‘A Quiet Place: Day One’ Photo Call
|
|
Jun 22
|
Insider Selling: Director Saira Ramasastry Sells Shares of Day One Biopharmaceuticals Inc (DAWN)
|
|
Jun 19
|
Day One targets the growing ADC market with MabCare acquisition
|
|
Jun 18
|
Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers
|
|
May 6
|
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
|
|
May 4
|
Insider Sale at Day One Biopharmaceuticals Inc (DAWN)
|
|
Apr 23
|
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
|
|
Mar 15
|
Companies Like Day One Biopharmaceuticals (NASDAQ:DAWN) Are In A Position To Invest In Growth
|
|
Mar 13
|
13 Best Biotech Stocks To Buy Under $20
|
|
Feb 28
|
Day One Biopharmaceuticals Inc (DAWN) Reports Q4 and Full Year 2023 Financial Results
|
|
Feb 26
|
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
|
|
Dec 19
|
Day One to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Nov 27
|
Milei to Send ‘Shock’ Package to Argentina’s Congress on Day One
|